• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli companies.

    Shavit Capital has over $200 million under management across four separate private equity funds. Shavit Capital was founded in 2008 and the fourth fund was raised in 2017.  These Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Kamada Exceeds 2017 Revenue Guidance of $100M and Becomes Cash Flow Positive
    February 7, 2018
    Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
    January 31, 2018
    Masonic Center at U of M Testing New Tech for Enhancing Anti-cancer ‘Killer
    January 24, 2018
    Gamida Cell Announces Initiation of a Phase I Study of NAM-NK Cells Immunothe
    January 16, 2018
    Intec Pharma Announces Development Collaboration With Global Pharmaceutical C
    January 8, 2018
    Foamix Announces Positive Results from Phase 3 Open-Label Safety Extension Ev
    January 4, 2018
    PolyPid Appoints Jacob Harel as Chairman of the Board of Directors
    December 21, 2017
    Gamida Cell reports positive cancer drug trial
    December 13, 2017
    Pharma Veteran Julian Adams takes Helm at Gamida Cell
    November 21, 2017
    Gamida Cell Appoints Julian Adams, Ph.D., Chairman and Chief Executive Office
    November 20, 2017